This page has tags:

1. 1 2016-08-18T06:50:05-07:00 Ken Londoner 67400b6d41c00fbf11f194dad77d72364b87b2e2 Media Files Ken Londoner 3 Tag: Media Files vistag 2017-02-17T05:41:53-08:00 Ken Londoner 67400b6d41c00fbf11f194dad77d72364b87b2e2

This page is referenced by:

• 1 2016-08-18T06:19:04-07:00 Ken Londoner with a Device for Complex Arrhythmia 3 plain 2018-12-11T12:18:52-08:00
  
  Targeting the growing electrophysiology (EP) device market that sits at around $3 billion, BioSig Technologies and its founder Ken Londoner are focused on developing a system that will improve the clarity of signals available for EP procedures, studies, and cardiac catheter ablation. Cardiac arrhythmia, or cardiac dysrhythmia, commonly known as an irregular heartbeat, is a condition, or better said a group of conditions, in which the heartbeat is irregular, either too fast, or too slow. The signs and symptoms of this condition can range from almost none existing to loss of consciousness and sudden cardiac death.
  
  Nowadays there is a number of tests available for its diagnosis, but as Kenneth Londoner states, due to its complexity, it is extremely important to proceed with a stepwise approach. Obtaining a correlation between symptoms, the underlying arrhythmia, and initiation of appropriate therapy is the main goal. In order to identify patients with arrhythmias who are at risk for sudden cardiac death, additional testing is usually recommended.
  
  Electrophysiologic testing is one way for identifying high-risk patients who have nonsustained VT. In fact, electrophysiologic testing is the gold standard for evaluating patients with recurrent syncope. For years now, led by its CEO, BioSig has been working on developing Pure EP proprietary technology platform, in order to improve the accuracy of clinical signals available for EP procedures. At the moment, there are around 4 million people in the US affected from atrial fibrillation, but only about 300,000 complex catheter procedures are performed in the US each year, which is a clear indicator of the severe disconnect in the market.
  
  About 20 years ago, the first traditional cardiac EP devices were designed and they were meant for treating less complex arrhythmias. As it became more and more obvious that there is an actual need for a device that can read more complex arrhythmias, savvy businessman Ken Londoner decided to invest in developing a system that can treat atrial fibrillation and ventricular tachyarrhythmia, and thus help millions of people. Today, not only have they developed a device that is able to read more complex arrhythmias, but has also found a way to get rid of the non-biological noise.
• 1 2022-01-25T04:27:22-08:00 Everything You Need to Know About ECG 2 plain 2022-01-25T04:27:49-08:00 Are you at risk for heart disease? Do you have high blood pressure? These are all questions that can be answered with a simple ECG test. A regular ECG test is one of the most common tests that are conducted to diagnose heart disease. You can also get a screening test for high blood pressure, cholesterol, and diabetes.

  What is an ECG test?

  An ECG test is a type of medical test that measures the function of the heart. It can be used to diagnose heart disease, such as high blood pressure, cholesterol, and diabetes.
  
  Ken Londoner, CEO of medical device company, BioSig Technologies, together with his team at BioSig have developed a signal processing platform that combines advanced hardware and software to address known challenges associated to signal acquisition. This enables electrophysiologists to see more signals, and analyze them in real-time. The platform is called PURE EP™.

   

  What are the benefits of having an ECG test?

  Ken Londoner indicates that the benefits of having an ECG test include a number of things. For example, if you have high blood pressure, you can get a screening test that will tell you whether or not you have hypertension. If you have cholesterol levels that are too high, you can get a test to lower those levels. If you have diabetes, you can get a test to see if it is present.

   

  What are the risks of not having an ECG test?

  Heart disease is one of the most common conditions that can be caused by a lack of an ECG test. High blood pressure and cholesterol can also be issues if you don't have an ECG test. These are all risks that can occur if you don't perform a regular ECG test.
  
  Ken Londoner’s PURE EP™ system has a range of proprietary hardware and software which enables cardiologists to capture the full spectrum of cardiac signals with high fidelity, while taking advantage of customizable software modules. All systems are adjustable in real-time by heart failure specialists to provide unlimited analysis options.

   

  What should you do if you don’t have an ECG test?

  If you don’t performed an ECG test, you should go for one as soon as possible. A regular ECG test can help you diagnose heart disease, such as atrial fibrillation and other health conditions. You can also use a screening test for high blood pressure, cholesterol, and diabetes. Ken Londoner indicates that a screening test is a quick and easy way to determine if you are at risk for developing any of these diseases.